New York State Department of Health
Video Controls
Program
Transcript/Transcripción
Help
view_quilt
Drug Utilization Review Board Meeting
movie
Player
reorder
bookmark
book
remove
panorama
add
autorenew
Program
reorder
clear
vertical_align_top
Drug Utilization Review Board Meeting
May 16, 2024
Welcome and Introductions
Public Comment
Preferred Drug Program (PDP) Review
1. Movement Disorder Agents
2. Multiple Sclerosis Agents
3. Anti-Fungals - Topical
4. Immunomodulators - Topical
5. Anabolic Steroids - Topical
6. Growth Hormones
Preferred Drug Program (PDP) Review Continued
7. Proton Pump Inhibitors (PPIs)
8. Hemophilia Agents - Factor VIII
9. Immunomodulators - Systemic
10. Anti-inflammatory/Immunomodulators - Ophthalmic
11. Non-Steroidal Anti-inflammatory Drugs (NSAIDs) - Ophthalmic
12. Phosphate Binders/Regulators
13. Rosacea Agents - Topical
PDP Recommendations
Transcript/Transcripción
reorder
clear
vertical_align_top
A
A
Español
Sync to Video
Search
search
keyboard_arrow_down
keyboard_arrow_up
cancel
Help
clear
